GV (Google Ventures)

Activity from announced rounds

Activity in this selectionUnited States

GV invests in technology and life-science companies, including AI applications, developer tools, cybersecurity, computing infrastructure and healthcare.

Its AI interests span the stack: new computing systems and inference infrastructure, tools for developers, software for professional workflows and applications in drug discovery and patient care. This gives both infrastructure founders and application builders a route to a specialist investment team.

GV developed the design sprint, a five-day process that takes a business question through problem definition, prototyping and customer testing. Its published sprint materials help teams test demand and product decisions before committing to a full launch.

Sources
Rounds participated in
33
Confirmed lead rounds
1
26 roles undisclosed
New companies
31
First participation on record · 2 follow-on
Funding in participating rounds
$21.3B
33 disclosed · full round size, not this investor’s share

By stage

Series C+11
Series B8
Series A6
Undisclosed4
Seed3
1 more
Growth1

By primary sector

Biotech7
Healthtech6
AI5
Cybersecurity5
Developer tools2
7 more
Fintech2
Climate tech1
Defense tech1
Enterprise software1
Foodtech1
Mobility1
Space tech1

By country

United States33

Rounds

33 in this selection
Blacksmith

Cloud infrastructure for building and testing software through continuous integration workflows.

$66MSeries C
Participant
Estuary Biotherapeutics

Estuary Biotherapeutics develops locally delivered gene therapies for patients with inherited polycystic kidney disease.

$93MSeries A
Participant
Allara

Virtual care for women with hormonal, metabolic and reproductive health needs.

$30MFunding
Participant
Armadin

Armadin develops AI agents that test attack paths across enterprise systems and show defenders how connected weaknesses could be exploited.

$255.5MSeries B
Participant
Snorkel AI

Snorkel AI helps enterprises build expert-curated training data and benchmarks for advanced AI models and agents.

$350MSeries E
Participant
Encoded Therapeutics Inc.

Encoded develops precision gene therapies for neurological disorders, led by ETX101, a gene-regulation therapy for people with SCN1A-positive Dravet syndrome.

$275MSeries F
Lead
Blacksmith

Cloud infrastructure for building and testing software through continuous integration workflows.

$45MSeries B
Role not disclosed
LifeMine Therapeutics

Develops fungal genome-derived therapeutics for organ transplant rejection

$263MSeries D+Series E
Role not disclosed
Obsidian Security

Secures non-human identities and AI agents operating in third-party applications

$85MSeries D
Role not disclosed
Wonder

A leading food technology platform built to make great food more accessible

$650MSeries D
Role not disclosed
Nebex

Builds market infrastructure connecting space companies with sovereign buyers and capital

$30MSeed
Role not disclosed
Odyssey

Builds general-purpose world models that simulate physical reality for robotics, gaming, and autonomous systems

$310MSeries B
Role not disclosed
Contraline

Develops hormonal and non-hormonal male contraceptives for men and couples globally

$92.5MSeries B
Role not disclosed
Signos, Inc.

Offers an FDA-cleared AI-powered glucose monitoring system for weight management and metabolic health

$20MGrowth
Role not disclosed
Flick

AI-native filmmaking platform giving creators cinematic control to direct AI-generated films

$6MSeed
Role not disclosed
Nectar Social

Provides AI infrastructure for modern marketing

$30MSeries A
Role not disclosed
Iterative Health

Develops technology and services for clinical research.

$77MSeries C
Role not disclosed
Wealth.com

Provides AI-powered estate and tax planning platform for wealth management firms

$65MSeries B
Role not disclosed
Censys

Provides Internet intelligence and insights for security operations and exposure management

$70MSeries D
Role not disclosed
Sift

Delivers AI data infrastructure for mission-critical machines across space, defense, and autonomy

$42MSeries B
Role not disclosed
Translucent

Provides AI platform for healthcare finance

$27MSeries A
Role not disclosed
Armadin

Armadin develops AI agents that test attack paths across enterprise systems and show defenders how connected weaknesses could be exploited.

$189.9MSeed+Series A
Role not disclosed
SambaNova

Provides next-generation AI infrastructure for enterprises, neo-clouds, and sovereign AI initiatives

$350MSeries E
Role not disclosed
Basis

Provides AI agents for accountants to complete complex accounting workflows end-to-end

$100MSeries B
Role not disclosed
Complyance

Uses AI agents to manage governance risk and data compliance for enterprises

$20MSeries A
Role not disclosed
Midi Health

Provides accessible, insurance-covered services in all 50 states for women's healthcare

$100MSeries D
Role not disclosed
Waymo

Waymo develops autonomous driving technology and operates a fully driverless ride-hailing service.

$16BInvestment round
Participant
OpenEvidence

Provides AI-powered medical search engine for clinicians

$250MSeries D
Role not disclosed
Humans&

Provides AI software to help people collaborate with each other

$480MSeed
Role not disclosed